Literature DB >> 16218190

Lamins A and C are differentially dysfunctional in autosomal dominant Emery-Dreifuss muscular dystrophy.

Isabell Motsch1, Manuja Kaluarachchi, Lindsay J Emerson, Charlotte A Brown, Susan C Brown, Marie-Christine Dabauvalle, Juliet A Ellis.   

Abstract

Mutations in the LMNA gene, which encodes nuclear lamins A and C by alternative splicing, can give rise to Emery-Dreifuss muscular dystrophy. The mechanism by which lamins A and C separately contribute to this molecular phenotype is unknown. To address this question we examined ten LMNA mutations exogenously expressed as lamins A and C in COS-7 cells. Eight of the mutations when expressed in lamin A, exhibited a range of nuclear mislocalisation patterns. However, two mutations (T150P and delQ355) almost completely relocated exogenous lamin A from the nuclear envelope to the cytoplasm, disrupted nuclear envelope reassembly following cell division and altered the protein composition of the mid-body. In contrast, exogenously expressed DsRed2-tagged mutant lamin C constructs were only inserted into the nuclear lamina if co-expressed with any EGFP-tagged lamin A construct, except with one carrying the T150P mutation. The T150P, R527P and L530P mutations reduced the ability of lamin A, but not lamin C from binding to emerin. These data identify specific functional roles for the emerin-lamin C- and emerin-lamin A- containing protein complexes and is the first report to suggest that the A-type lamin mutations may be differentially dysfunctional for the same LMNA mutation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16218190     DOI: 10.1016/j.ejcb.2005.04.004

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  8 in total

Review 1.  Do lamin A and lamin C have unique roles?

Authors:  Rasha Al-Saaidi; Peter Bross
Journal:  Chromosoma       Date:  2014-10-07       Impact factor: 4.316

2.  Specific contribution of lamin A and lamin C in the development of laminopathies.

Authors:  Nicolas Sylvius; Andrea Hathaway; Emilie Boudreau; Pallavi Gupta; Sarah Labib; Pierrette M Bolongo; Peter Rippstein; Heidi McBride; Zofia T Bilinska; Frédérique Tesson
Journal:  Exp Cell Res       Date:  2008-05-10       Impact factor: 3.905

3.  Morphological analysis of 13 LMNA variants identified in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.

Authors:  Jason Cowan; Duanxiang Li; Jorge Gonzalez-Quintana; Ana Morales; Ray E Hershberger
Journal:  Circ Cardiovasc Genet       Date:  2009-11-17

4.  Phenotype-Genotype Analysis of Chinese Patients with Early-Onset LMNA-Related Muscular Dystrophy.

Authors:  Dandan Tan; Haipo Yang; Yun Yuan; Carsten Bonnemann; Xingzhi Chang; Shuang Wang; Yuchen Wu; Xiru Wu; Hui Xiong
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

5.  The effect of the lamin A and its mutants on nuclear structure, cell proliferation, protein stability, and mobility in embryonic cells.

Authors:  Katarzyna Piekarowicz; Magdalena Machowska; Ewelina Dratkiewicz; Daria Lorek; Agnieszka Madej-Pilarczyk; Ryszard Rzepecki
Journal:  Chromosoma       Date:  2016-08-17       Impact factor: 4.316

Review 6.  Cellular and Animal Models of Striated Muscle Laminopathies.

Authors:  Hannah A Nicolas; Marie-Andrée Akimenko; Frédérique Tesson
Journal:  Cells       Date:  2019-03-29       Impact factor: 6.600

7.  Mammalian SUN protein interaction networks at the inner nuclear membrane and their role in laminopathy disease processes.

Authors:  Farhana Haque; Daniela Mazzeo; Jennifer T Patel; Dawn T Smallwood; Juliet A Ellis; Catherine M Shanahan; Sue Shackleton
Journal:  J Biol Chem       Date:  2009-11-21       Impact factor: 5.157

Review 8.  Diverse lamin-dependent mechanisms interact to control chromatin dynamics. Focus on laminopathies.

Authors:  Daria Camozzi; Cristina Capanni; Vittoria Cenni; Elisabetta Mattioli; Marta Columbaro; Stefano Squarzoni; Giovanna Lattanzi
Journal:  Nucleus       Date:  2014 Sep-Oct       Impact factor: 4.197

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.